Why the study?
Do patients with mental disorders experience disparities in the screening and treatment of cardiovascular diseases?
Do patients with mental disorders experience disparities in the screening and treatment of cardiovascular diseases?
There are significant global disparities in cardiovascular care for patients with mental disorders, highlighting a critical need to address underprescribing and underutilization of CVD diagnostics and therapies in this population.
Clinicians must close CVD care gaps for mental disorder patients via equitable screening and treatment; confirms disparities and extends equity research priorities.
People with mental disorders, and those with schizophrenia in particular, receive less screening and lower-quality treatment for CVD. It is of paramount importance to address underprescribing of CVD medications and underutilization of diagnostic and therapeutic procedures across all mental disorders.
No takes yet. Share an insight, caveat, or question.
Solmi et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: